A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

January 31, 2004

Conditions
PapillomaRecurrent Respiratory Papillomatosis
Interventions
DRUG

SGN-00101

Trial Locations (8)

23507

Children's Hospital of the King's Daughters, Norfolk

32207

Nemour's Childrens Clinic, Division of Pediatric Oncology, Jacksonville

35233

Children's Hospital of Alabama, Birmingham

44106

University Hospitals of Cleveland, Cleveland

52242

University of Iowa Hospitals and Clinics, Iowa City

55455

Fairview University Medical Center, University of Minnesota, Minneapolis

72202

University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock

75390

University of Texas, Southwestern Medical School, Dallas

All Listed Sponsors
lead

Nventa Biopharmaceuticals Corporation

INDUSTRY